[go: up one dir, main page]

FI972754A - Uusi monoklonaalinen vasta-aine, jolla on tyypin II fosfolipaasia A2 inhiboiva aktiivisuus, ja tämän osan sisältävä proteiini - Google Patents

Uusi monoklonaalinen vasta-aine, jolla on tyypin II fosfolipaasia A2 inhiboiva aktiivisuus, ja tämän osan sisältävä proteiini Download PDF

Info

Publication number
FI972754A
FI972754A FI972754A FI972754A FI972754A FI 972754 A FI972754 A FI 972754A FI 972754 A FI972754 A FI 972754A FI 972754 A FI972754 A FI 972754A FI 972754 A FI972754 A FI 972754A
Authority
FI
Finland
Prior art keywords
phospholipase
moiety
type
monoclonal antibody
inhibitory activity
Prior art date
Application number
FI972754A
Other languages
English (en)
Swedish (sv)
Other versions
FI972754A0 (fi
Inventor
Yasushi Kawauchi
Jun Takasaki
Tomoe Yasunaga
Yasuhiko Masuho
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of FI972754A0 publication Critical patent/FI972754A0/fi
Publication of FI972754A publication Critical patent/FI972754A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI972754A 1994-12-29 1997-06-26 Uusi monoklonaalinen vasta-aine, jolla on tyypin II fosfolipaasia A2 inhiboiva aktiivisuus, ja tämän osan sisältävä proteiini FI972754A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34000694 1994-12-29
PCT/JP1995/002714 WO1996020959A1 (fr) 1994-12-29 1995-12-27 Nouvel anticorps monoclonal ayant un effet inhibiteur sur la phospholipase a2 de type ii, et proteine contenant une partie de cet anticorps

Publications (2)

Publication Number Publication Date
FI972754A0 FI972754A0 (fi) 1997-06-26
FI972754A true FI972754A (fi) 1997-06-26

Family

ID=18332850

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972754A FI972754A (fi) 1994-12-29 1997-06-26 Uusi monoklonaalinen vasta-aine, jolla on tyypin II fosfolipaasia A2 inhiboiva aktiivisuus, ja tämän osan sisältävä proteiini

Country Status (11)

Country Link
EP (1) EP0799836A1 (fi)
KR (1) KR970707162A (fi)
CN (1) CN1171792A (fi)
AU (1) AU4355496A (fi)
CA (1) CA2204731A1 (fi)
FI (1) FI972754A (fi)
HU (1) HUT77041A (fi)
NO (1) NO973026L (fi)
NZ (1) NZ298145A (fi)
PL (1) PL321161A1 (fi)
WO (1) WO1996020959A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3276197A (en) * 1996-06-27 1998-01-14 Yamanouchi Pharmaceutical Co., Ltd. Drugs for ameliorating renal disorders
US6197582B1 (en) 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
EP1084108A4 (en) * 1998-05-01 2005-01-12 Lilly Co Eli SPLA 2 INHIBITORS FOR THE TREATMENT OF DISEASES
WO2001066110A2 (en) * 2000-03-09 2001-09-13 Eli Lilly And Company METHOD FOR THE TREATMENT OF RENAL DYSFUNCTION WITH sPLA2 INHIBITORS
US7060802B1 (en) 2000-09-18 2006-06-13 The Trustees Of Columbia University In The City Of New York Tumor-associated marker
DE10219545A1 (de) * 2002-04-26 2003-11-06 Lang Florian Regulation der Apoptose
US20090191213A9 (en) 2003-07-02 2009-07-30 Novo Nordisk A/S Compositions and methods for regulating NK cell activity
EP1673397B1 (en) 2003-07-02 2010-12-08 Novo Nordisk A/S Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies
WO2005028653A1 (en) 2003-09-22 2005-03-31 Biospecific Gmbh & Co. Kg Method for neutralizing effects of secreted pla2 iia
DK2287195T3 (da) 2004-07-01 2019-08-19 Innate Pharma Pan-kir2dl nk-receptor-antistoffer og anvendelse heraf i diagnostik og terapi
BRPI0714871A2 (pt) * 2006-07-18 2013-05-07 Sanofi Aventis anticorpo antagonista para o tratamento de cÂncer
EP2581388A1 (en) * 2011-10-14 2013-04-17 Centre National de la Recherche Scientifique (CNRS) Anti-sPLA2-V antibodies and uses thereof
AU2014298373B2 (en) 2013-08-01 2019-12-05 Ludwig Institute For Cancer Research Ltd Anti-GARP protein and uses thereof
EP2832747A1 (en) * 2013-08-01 2015-02-04 Université Catholique de Louvain Anti-GARP protein and uses thereof
WO2016073747A1 (en) * 2014-11-06 2016-05-12 The Trustees Of The University Of Pennsylvania Atomic description of immune complex that causes heparin-induced thrombocytopenia
GB201707561D0 (en) 2017-05-11 2017-06-28 Argenx Bvba GARP-TGF-beta antibodies
CN108840918B (zh) * 2018-06-14 2021-07-23 浙江农林大学 Pla2抑制剂编码基因的克隆方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0717680B2 (ja) * 1987-04-15 1995-03-01 塩野義製薬株式会社 ヒト▲膵▼ホスホリパ−ゼa▲下2▼に対するモノクロ−ナル抗体、その製造法、該モノクロ−ナル抗体産生ハイブリド−マおよび該モノクロ−ナル抗体を用いたヒト▲膵▼ホスホリパ−ゼa▲下2▼の測定方法
JP2984029B2 (ja) * 1990-05-30 1999-11-29 塩野義製薬株式会社 膜型ホスホリパーゼa▲下2▼を認識するモノクローナル抗体および膜型ホスホリパーゼa▲下2▼の免疫測定法
JPH07109300A (ja) * 1993-10-13 1995-04-25 Teijin Ltd ヒトii型ホスホリパーゼa2と結合する抗体

Also Published As

Publication number Publication date
MX9704879A (es) 1997-11-29
EP0799836A1 (en) 1997-10-08
FI972754A0 (fi) 1997-06-26
CN1171792A (zh) 1998-01-28
WO1996020959A1 (fr) 1996-07-11
HUT77041A (hu) 1998-03-02
NO973026D0 (no) 1997-06-27
AU4355496A (en) 1996-07-24
NO973026L (no) 1997-08-29
NZ298145A (en) 1998-08-26
PL321161A1 (en) 1997-11-24
CA2204731A1 (en) 1996-07-11
KR970707162A (ko) 1997-12-01

Similar Documents

Publication Publication Date Title
FI972754A (fi) Uusi monoklonaalinen vasta-aine, jolla on tyypin II fosfolipaasia A2 inhiboiva aktiivisuus, ja tämän osan sisältävä proteiini
DE69624071D1 (de) Eingeschlossener Motortyp
EP0797659A4 (en) INSECTICIDE PROTEIN TOXINS FROM PHOTORHABDUSES
BR9601190A (pt) Chumaço reagente
DK0815208T3 (da) Amylasevarianter
DE69604881D1 (de) Lichtempfindliches, wärmeentwickelbares Material
NO955167D0 (no) Monoklonalt anti-
DE68914244D1 (de) Monoklonaler Antikörper.
NO970539D0 (no) Behandlingselement for en sentrifuge
DE69528180D1 (de) Modifiziertes molkeprotein
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
DE59611147D1 (de) Flugzeugtragelement
FI972430A (fi) Immunosuppressiivista aktiivisuutta sisältäviä monoklonaalisen vasta-aineen fragmentteja
NO982084D0 (no) Pesticidpreparat
NO894444D0 (no) Anti-fucosylceramid monoklonalt antistoff.
FR2737399B1 (fr) Couvert ergonomique
NO890116D0 (no) Monoklonale antistoffer.
KR970011932U (ko)
DE68916088D1 (de) Anti-CPBII-monoklonaler Antikörper.
KR970010541U (ko) 배기통
BR1100504A (pt) anticorpos anti-ige.
KR970040368U (ko) 로커 커버
ES1030090Y (es) Bovedilla aligerada con lengueta.
KR970012423U (ko) 앨범표지
ATA60395A (de) Abdeckelement

Legal Events

Date Code Title Description
FD Application lapsed